SCHEMBL20723484

SCHEMBL20723484

NCCCC[C@H](N)C(=O)N[C@H](CCCCN)C(=O)O

nearest known ligand 0.60

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
GSR P00390 1/20 0.60
FOLH1 Q04609 1/20 0.58
DPP8 Q6V1X1 2/20 0.51
DPP9 Q86TI2 2/20 0.51
DPP7 Q9UHL4 2/20 0.51
CPB2 Q96IY4 6/20 0.48
GNAI3 P08754 1/20 0.47
GNAO1 P09471 1/20 0.47
GNAI1 P63096 1/20 0.47
SLC6A5 Q9Y345 1/20 0.46
NOD1 Q9Y239 1/20 0.46
DPP4 P27487 1/20 0.45
SLC15A2 Q16348 1/20 0.45
ERAP2 Q6P179 1/20 0.45
ERAP1 Q9NZ08 1/20 0.45
LNPEP Q9UIQ6 1/20 0.45
MMP2 P08253 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30890373 1.00 GSR (0.60) GSRFOLH1DPP8DPP9DPP7
SCHEMBL20723487 1.00 GSR (0.60) GSRFOLH1DPP8DPP9DPP7
SCHEMBL1070057 1.00 GSR (0.60) GSRFOLH1DPP8DPP9DPP7
SCHEMBL30076247 1.00 GSR (0.60) GSRFOLH1DPP8DPP9DPP7
SCHEMBL8616589 1.00 GSR (0.60) GSRFOLH1DPP8DPP9DPP7
SCHEMBL1070055 1.00 GSR (0.60) GSRFOLH1DPP8DPP9DPP7
SCHEMBL17696519 1.00 GSR (0.60) GSRFOLH1DPP8DPP9DPP7
Hydrochloric Acid SCHEMBL4328805 0.98 GSR (0.58) GSRFOLH1DPP8DPP9DPP7
Hydrochloric Acid SCHEMBL10439913 0.98 GSR (0.58) GSRFOLH1DPP8DPP9DPP7
Hydrochloric Acid SCHEMBL1419587 0.98 GSR (0.58) GSRFOLH1DPP8DPP9DPP7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118791566-A Low-toxicity broad-spectrum antibacterial peptide with unnatural amino acid and application thereof 兰州大学 2024-10-18 CN disclosed
US-20240335551-A1 FUNCTIONAL MOIETIES AND THEIR USES AND SYNTHETIC PREPARATION OLIX US, INC. 2024-10-10 US disclosed
US-11925688-B2 Compositions and methods relating to salts of specialized pro-resolving mediators THETIS PHARMACEUTICALS LLC (US) 2024-03-12 US disclosed
CN-111902394-B Compositions and methods relating to salts of specific pro-inflammatory regressive mediators 西蒂斯制药有限责任公司 2024-03-08 CN disclosed
CN-109562186-B Compositions and methods relating to salts of specialized proresolving mediators 西蒂斯制药有限责任公司 2022-09-13 CN disclosed
CN-108350046-B Analogs of VDAC 1-derived peptides 在本-古里安大学的B.G.内盖夫科技与应用有限公司 2022-04-01 CN disclosed
EP-3665161-A1 NEW TARGETED CYTOTOXIC RATJADONE DERIVATIVES AND CONJUGATES THEREOF Helmholtz-Zentrum für Infektionsforschung GmbH (DE) 2020-06-17 EP disclosed
WO-2019030284-A1 NEW TARGETED CYTOTOXIC RATJADONE DERIVATIVES AND CONJUGATES THEREOF Helmholtz-Zentrum für Infektionsforschung GmbH (DE) 2019-02-14 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11925688-B2 Compositions and methods relating to salts of specialized pro-resolving mediators ALOX15B, LTB4R2, ALOX5 GSR 705/4885FOLH1 1989/4885DPP8 3089/4885
US-20240335551-A1 FUNCTIONAL MOIETIES AND THEIR USES AND SYNTHETIC PREPARATION FGB, SELP, PTMS GSR 1333/4885FOLH1 225/4885DPP8 1254/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.